ATPCI: Trimetazidine Fizzles for Post-PCI Angina
Adding trimetazidine to optimum medical therapy doesn’t make stronger outcomes following successful percutaneous coronary intervention (PCI) for staunch angina or a non–ST-elevated myocardial infarction (MI), results of the ATPCI trial picture. There used to be no merit for the composite…